Aspira Women's Health Inc. is a commercial-stage diagnostics company focused on gynecological disease detection in women. The company develops and markets diagnostic tests including Ova1, Overa, Ova1Plus, OvaWatch, ENDOinform, and OVAinform for ovarian cancer risk assessment, endometriosis, and benign pelvic mass monitoring. Operating through its laboratory subsidiary Aspira Labs, the company also offers the Aspira Synergy platform and Aspira Genetix genetic testing services.
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-04-01 | 2025-12-31 | 0000926617-26-000020 | EDGAR | 64K words |
| 2025-03-27 | 2024-12-31 | 0001641172-25-000983 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0000926617-24-000015 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0000926617-23-000026 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0000926617-22-000014 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0000926617-21-000033 | EDGAR | — |
| 2020-04-07 | 2019-12-31 | 0000926617-20-000015 | EDGAR | — |
| 2019-03-28 | 2018-12-31 | 0000926617-19-000007 | EDGAR | — |
| 2018-03-13 | 2017-12-31 | 0000926617-18-000012 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0000926617-17-000023 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0000926617-25-000008 | EDGAR | 28K words |
| 2025-08-13 | 2025-06-30 | 0001493152-25-011865 | EDGAR | — |
| 2025-05-19 | 2025-03-31 | 0001641172-25-011399 | EDGAR | — |
| 2024-11-19 | 2024-09-30 | 0001493152-24-046836 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096220 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060401 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0000926617-23-000095 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000926617-23-000070 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000926617-23-000046 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000926617-22-000058 | EDGAR | — |
| 2022-08-10 | 2022-06-30 | 0000926617-22-000052 | EDGAR | — |
| 2022-05-11 | 2022-03-31 | 0000926617-22-000032 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-15 | 0000926617-26-000052 | EDGAR | — |
| 2026-01-30 | 0000926617-26-000007 | EDGAR | 14K words |
| 2025-12-31 | 0000926617-25-000014 | EDGAR | — |
| 2025-12-23 | 0001104659-25-124245 | EDGAR | — |
| 2025-12-22 | 0000926617-25-000010 | EDGAR | — |
| 2025-11-14 | 0000926617-25-000004 | EDGAR | — |
| 2025-10-15 | 0001493152-25-018146 | EDGAR | — |
| 2025-09-25 | 0001493152-25-014925 | EDGAR | — |
| 2025-09-18 | 0001493152-25-013987 | EDGAR | — |
| 2025-09-03 | 0001641172-25-026441 | EDGAR | — |
382 total filings indexed. 350 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000926617 |
| Ticker | AWHL |
| Exchange | OTC |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AWHL (~200 tokens, structured JSON with cryptographic provenance)